Abstract
Most anticancer drugs used to treat cancer patients have a noticeable
immunosuppressive effect, therefore, the characteristics of each new anticancer drug
necessarily include the study of its effect on the immunological reactions of the
body.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2025 Enikeeva Z.M., Urazov N.E., Ibragimov Sh.N., Agzamova N.A